Concizumab in hemophilia with inhibitors: longer-term efficacy and safety results from the phase 3 explorer7 study by Exceedion, LLC | Mar 24, 2026
Massive Intra-Abdominal Pseudotumor in a Patient With Hemophilia A Treated With Emicizumab: A Case Report by Exceedion, LLC | Jan 4, 2026
Measuring FVIII Activity and Thrombin Generation Simultaneously With a Novel Point of Care Platform (EnzySystem HemA): Qualitative Usability Evaluation by Exceedion, LLC | Oct 16, 2025
Evaluation of kidney function and damage in patients with hemophilia B—insights from the B-Natural study by Exceedion, LLC | Oct 1, 2025
Treatment and Disease Burden in a Cohort of People With Hemophilia Without Inhibitors in the United States by Exceedion, LLC | Jun 27, 2025